|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| 20/07/16 | Meda : Mylan gets EU approval for Meda purchase, subject to conditions | RE |
| 15/07/16 | Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | - | |
Mårten Österlund
LAW | General Counsel | 69 | 08/12/2014 |
Rainer Weiss
CTO | Chief Tech/Sci/R&D Officer | 64 | 31/12/2004 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 24/08/2016 | |
| Director/Board Member | 58 | 24/08/2016 | |
| Chairman | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.63% | -7.91% | +46.17% | +150.07% | 1T | |
| -0.81% | -5.49% | +47.39% | +49.13% | 613B | |
| -0.49% | -7.21% | +23.85% | +65.32% | 433B | |
| +0.65% | -2.61% | +40.51% | +35.18% | 350B | |
| +0.17% | -4.31% | +31.93% | +40.09% | 292B | |
| +2.22% | -9.38% | +5.30% | +7.48% | 239B | |
| +1.75% | -8.29% | -1.73% | -42.05% | 206B | |
| +1.26% | -2.47% | +26.98% | +57.59% | 204B | |
| -0.48% | -2.67% | +14.17% | +66.17% | 163B | |
| Average | +0.54% | -3.88% | +26.06% | +47.66% | 388.94B | |
| Weighted average by Cap. | +0.36% | -4.34% | +33.65% | +70.90% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
